PRESS RELEASE published on 02/21/2025 at 07:30, 2 months 7 days ago Informations privilégiées / Autres communiqués Sensorion reçoit une recommandation positive du Comité de Surveillance des Données pour la poursuite de l'essai clinique Audiogene avec le SENS-501. La sécurité du programme de thérapie génique est confirmée. Fin du recrutement de la seconde cohorte prévue pour 2025 Phase 1/2 Sensorion SENS-501 Audiogene Comité De Surveillance
PRESS RELEASE published on 02/21/2025 at 07:30, 2 months 7 days ago Inside Information / Other news releases Sensorion receives positive recommendation from Data Monitoring Committee for Audiogene Phase 1/2 clinical trial of SENS-501 gene therapy program to treat congenital deafness linked to OTOF gene mutations Gene Therapy Sensorion Audiogene Deafness Data Monitoring Committee
BRIEF published on 02/20/2025 at 07:35, 2 months 8 days ago Sensorion participera aux conférences investisseurs de mars Biotechnologie Conférences D'investisseurs Sensorion Thérapies Pour La Perte Auditive Mars 2025
BRIEF published on 02/20/2025 at 07:35, 2 months 8 days ago Sensorion to Participate in March Investor Conferences Biotechnology Investor Conferences Sensorion Hearing Loss Therapies March 2025
PRESS RELEASE published on 02/20/2025 at 07:30, 2 months 8 days ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à plusieurs conférences investisseurs en mars 2025 pour présenter ses thérapies contre la perte auditive. Détails sur les événements et les intervenants Biotechnologie Conférences Investisseurs Sensorion Perte Auditive Thérapies
PRESS RELEASE published on 02/20/2025 at 07:30, 2 months 8 days ago Inside Information / Other news releases Sensorion announces participation in investor conferences in March. CEO and CFO will attend Cowen and Leerink events to present company updates and meet investors Biotechnology CFO Investor Conferences CEO Sensorion
BRIEF published on 02/18/2025 at 07:35, 2 months 10 days ago Sensorion annonce sa participation à des congrès en mars 2025 Biotechnologie Sensorion Thérapies Auditives Innovations Médicales Congrès 2025
BRIEF published on 02/18/2025 at 07:35, 2 months 10 days ago Sensorion announces its participation in congresses in March 2025 Biotechnology Sensorion Hearing Therapies Medical Innovations Congress 2025
PRESS RELEASE published on 02/18/2025 at 07:30, 2 months 10 days ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à plusieurs congrès en mars 2025. Impliqué dans le développement de thérapies pour les troubles de la perte auditive, Sensorion participera à des événements scientifiques majeurs Développement Biotechnologie Congrès Sensorion Thérapies Auditives
PRESS RELEASE published on 02/18/2025 at 07:30, 2 months 10 days ago Inside Information / Other news releases Sensorion announces participation in upcoming congresses in March to present on innovative biologics and manufacturing challenges for hearing loss disorders Sensorion Hearing Loss Biologics Congresses Manufacturing Challenges
Published on 05/01/2025 at 02:00, 23 minutes ago EQ Inc. Reports Profitable Fourth Quarter and 2024 Year End Financial Results
Published on 05/01/2025 at 00:00, 2 hours 23 minutes ago Tecogen Announces Uplist to NYSE American Stock Exchange
Published on 04/30/2025 at 23:30, 2 hours 53 minutes ago Arras Minerals Announces Voting Results of Annual and Special Meeting of Shareholders
Published on 04/30/2025 at 23:20, 3 hours 3 minutes ago Justera Health Announces Director Resignation and Change to Fiscal Year End
Published on 04/30/2025 at 23:15, 3 hours 8 minutes ago Interactive Strength Inc. (Nasdaq:TRNR) Provides Shareholder Update on 2025 Developments
Published on 04/30/2025 at 23:30, 2 hours 52 minutes ago EEII AG: Ad-Hoc announcement pursuant to Art. 53 Listing Rules: EEII AG 2024 Annual Results
Published on 04/30/2025 at 22:43, 3 hours 39 minutes ago Assemblée générale ordinaire d’Espace Real Estate Holding AG
Published on 04/30/2025 at 21:15, 5 hours 8 minutes ago voxeljet AG announces financial restructuring with StaRUG procedure after general meeting rejects approval of the sale of the business to Anzu
Published on 04/30/2025 at 21:00, 5 hours 23 minutes ago Northern Data Group issues Business and Operational Update
Published on 04/30/2025 at 20:40, 5 hours 42 minutes ago EQS-Adhoc: Northern Data Group Updates 2025 Guidance and Provides New Guidance Framework
Published on 04/30/2025 at 19:14, 7 hours 8 minutes ago Report de la publication des résultats annuels 2024
Published on 04/30/2025 at 19:14, 7 hours 8 minutes ago Solocal - Communiqué de presse - Mise à disposition du DEU 2024
Published on 04/30/2025 at 18:55, 7 hours 27 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 5, 2025
